Clinical Trial Update: Assess if Immune Response of GSK Biologicals' Tritanrix™-HepB/Hib-MenAC Given Without or With Hepatitis B Vaccine at Birth is at Least as Good as Tritanrix™-HepB/Hiberix™ Without Hepatitis B Vaccine at Birth, When Given to Healthy Infants [Phase 3]

View source ↗

Summary

This Phase 3 trial in healthy infants evaluated whether giving Tritanrix-HepB/Hib-MenAC with a birth-dose Hepatitis B vaccine yields an immune response that is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Haemophilus Influenzae Type Disease
• Hepatitis B
• Pertussis
• Tetanus

Drugs mentioned

• Tritanrix-HepB/Hib-MenAC
• Tritanrix-HepB/Hiberix

Snippet

Sponsor: GlaxoSmithKline | Conditions: Haemophilus Influenzae Type b, Diphtheria | Phase 3 | Status: COMPLETED